Fooderapy is an innovativehealthy foodstartup whose goal is to offer healthy meals at home and tailored to everyone's needs, thanks to the work of specialist dieticians in collaboration with expert chefs. The project stems from the now consolidated evidence that...
“Microbiota, the secret weapon of the immune system. Knowing and taking care of the best friend of our health "is the new book written by Prof. Maria Rescigno, Head of the Mucosal and Microbiota Immunology Unit of the Hospital and Humanitas University and Co-founder...
The third edition of the World of Microbiome Conference, an international congress dedicated to the study and research in the microbiome field, was held in Vienna from 28 to 30 April. The conference was animated by a large panel of professionals in the field of...
The project “L’onda Covid: capire per reagire”, a cycle of conferences with internationally renowned Italian scientists coordinated by the magazine of the University of Padova “Il Bo Live” to approach the Genoa Science Festival, hosted Prof. Maria Rescigno, Head of...
The work of the Mucosal and Microbiota Immunology Laboratory directed by Prof. Maria Rescigno at Humanitas Research Hospital will be published in The Journal Of Urology. The dogma that urine is sterile has been overturned and dysbiosis of the urinary microbiome has...
Our Founder, Prof. Maria Rescigno, Head of Mucosal Immunology and Microbiota Unit of Humanitas Hospital and University, releases an interview to journalist Eliana Liotta within the program: ‘Health, the word to female scientists’. ...
What are prebiotics, probiotics and postbiotics? Our Founder Prof. Maria Rescigno, one of the world's leading experts on the subject, speaks. ...
The work of the Mucosal and Microbiota Immunology Laboratory directed by Prof. Maria Rescigno at Humanitas Research Hospital and supported by the AIRC foundation, led to the publication in Nature Microbiology of the paper regarding the identification of endogenous...
The 25th edition of the Ifscc conference, an international event dedicated to cosmetological sciences promoted by the International Federation of Chemical Products Companies, has witnessed two important contributions by our company. Postbiotica, represented by the...
Postbiotica has signed a licensing agreement with Kalichem(a Lamberti company) leader in the dermocosmetic market, based on a well established R&D collaboration. Kalichem develops and commercializes functional ingredients for cosmetics and medical devices. The...
Necrotizing enterocolitis (NEC) primarily affects premature newborns, occurring in 7–10% of very low birth weight infants, from 2 weeks to 2 months of age, with an incidence inversely related to gestational age (Patel et al. 2015). It is associated with a mortality as...
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of cardiometabolic syndrome, which often also includes obesity, diabetes, and dyslipidemia. It is rapidly becoming the most prevalent liver disease worldwide. A sizable minority of NAFLD patients...
Gut bacteria depend fully on their host to provide the necessary nutrients that may promote microbiota growth. However, bacteria produce small molecular weight metabolites during their lifecycle; these compounds play a key role in regulating self-growth, development,...
The human gut is the habitat to trillions of microbial cells with over 1,000 diverse microbial species that contribute to the primary functions of the gastrointestinal tract, including nutrition and defense. On the other hand, the gastrointestinal tract mucosa...
Postbiotica, represented by Francesca Algieri, won the first edition of the My Start BCN contest and has been rewarded by the President of the Chamber of Commerce, Igor Garzesi. Postbiotica has impressed the jury for the development of new metabolities derivated from...
Postbiotica has presented the new technology to modulate the production of bacterial metabolites, called Postbiotics. Postbiotica has been selected among 151 projects by Bioupper. Bioupper is a training and acceleration platform and converts and enhances he best ideas...
Maria Rescigno, professor and entrepreneur, co-founder of POSTBIOTICA, an innovative biopharmaceutical StartUp winner of the "MYSTART BCN" competition, is interviewed by "Italiani Anywhere".